Vimarsana
Biggest News Aggregation in the World

Adjusted Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adjusted Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adjusted Group Today - Breaking & Trending Today

Evotec reports Q1 2024 results and provides corporate update - Vimarsana News

Evotec reports Q1 2024 results and provides corporate update

Published: May 22, 2024

EQS-News: Evotec SE / Key word: Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate update 22.05.2024 / 07:00 CET/CEST The issuer is...

Source: marketscreener.com
Related Topics:
Basse NormandieWorth An Der DonauMario PolywkaGabriele HansenChristian WojczewskiVolker BraunEvotec BiologicsHinnerk RohwedderMarcy LyonHead Of Global Corporate CommunicationsCrohn Colitis FoundationHealth IngredientsCrohn Colitis Foundation TheGlobal Corporate CommunicationsVariant Bio IncEvotec Biologics IncBristol Myers SquibbBioscience Laboratories IncEvotec Se Frankfurt Stock ExchangeEvotec GroupFrankfurt Stock ExchangeColitis FoundationClaris VenturesChief People OfficerChief Executive Officer
EQS-News: Evotec reports Q1 2024 results and provides corporate update - Vimarsana News

EQS-News: Evotec reports Q1 2024 results and provides corporate update

Published: May 22, 2024

EQS-News: EVOTEC SE / Key word(s): Quarterly / Interim Statement Evotec reports Q1 2024 results and provides corporate updat...

Source: businessinsider.com
Related Topics:
Basse NormandieWorth An Der DonauMario PolywkaCrohn ColitisfoundationHinnerk RohwedderChristian WojczewskiMarcy LyonGabriele HansenVolker BraunEvotec BiologicsEvotec Se Frankfurt Stock ExchangeCrohn Colitis Foundation TheEvotec GroupBioscience Laboratories IncHealth IngredientsBristol Myers SquibbGlobal Corporate CommunicationsCrohn Colitis FoundationEvotec Biologics IncHead Of Global Corporate CommunicationsVariant Bio IncFrankfurt Stock ExchangeColitis FoundationClaris VenturesChief People Officer
Evotec : Interim STATEMENT 3M 2024 - Form 6-K - Vimarsana News

Evotec : Interim STATEMENT 3M 2024 - Form 6-K

Published: May 22, 2024

Interim STATEMENT 3M 2024 HIGHLIGHTS 4 CHALLENGING Q1 WITH...

Source: marketscreener.com
Related Topics:
Mario PolywkaChristian WojczewskiEvotec BiologicsMarcy LyonEvotec Biologics IncEvotec GroupJust Evotec Biologics IncBristol Myers SquibbColitis FoundationClaris VenturesVariant BioChief People OfficerChief Executive OfficerAdjusted GroupJust Evotec BiologicsTotal LiquidityBiologics IncCorporate Income TaxAnnual ReportManagement BoardOff External Cyber Related Costs
Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript - Vimarsana News

Evotec SE (NASDAQ:EVO) Q4 2023 Earnings Call Transcript

Published: April 26, 2024

Evotec SE misses on earnings expectations. Reported EPS is $-0.05 EPS, expectations were $-0.03333.

Source: insidermonkey.com
Related Topics:
United StatesMario PolywkaCharles WestonChristian WojczewskiJacqueline KisaSteven MahMichael RyskinCraig JohnstonMoritz NikolausPeter VerdultMatthias EversEvotec BiologicsVolker BraunOur GroupCountries That Increased Oil Production The MostBiggest Gold CompaniesEaton Vance Ohio Municipal Income TrustOur Adjusted GroupCall Transcript AprilIm Moritz NikolausSupervisory BoardLaetitia RouxelChief Financial OfficerChief Business OfficerChief Operating Officer
Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset ... - Vimarsana News

Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset ...

Published: April 24, 2024

Evotec Presents Fiscal Year 2023 Results and Announces Priority Reset ...

Source: pr-inside.com
Related Topics:
Christian WojczewskiMario PolywkaEvotec BiologicsBristol Myers SquibbEvtexecute Evtinnovate IntersegmentEvotec Se Frankfurt Stock ExchangeEvotec GroupNews NetworkFrankfurt Stock ExchangeBiologics Evotec Partner JingxinChina ApprovalScience Based TargetsChief Executive OfficerChief People OfficerAdjusted GroupInterim Chief Executive Officer